Community use of anthracyclines for adjuvant HER2-positive breast cancer (BC).

被引：0
|
作者：
Kumar, Akhil [1 ]
Fishman, Marc L. [1 ]
Shimp, William S. [1 ]
Bobolts, Laura Rose [1 ]
Krook, James Edward [1 ]
Fishman, Val [1 ]
Davis, Sharon [1 ]
Huff, Dinah [1 ]
Anthony, Carol [1 ]
Walton, Robert [1 ]
Hrushesky, William J. [1 ]
机构：
[1] Oncol Analyt Inc, Plantation, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11609
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Adjuvant Trastuzumab in HER2-Positive Breast Cancer
    Slamon, Dennis
    Eiermann, Wolfgang
    Robert, Nicholas
    Pienkowski, Tadeusz
    Martin, Miguel
    Press, Michael
    Mackey, John
    Glaspy, John
    Chan, Arlene
    Pawlicki, Marek
    Tamas Pinter
    Valero, Vicente
    Liu, Mei-Ching
    Sauter, Guido
    von Minckwitz, Gunter
    Visco, Frances
    Bee, Valerie
    Buyse, Marc
    Bendahmane, Belguendouz
    Tabah-Fisch, Isabelle
    Lindsay, Mary-Ann
    Riva, Alessandro
    Crown, John
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (14): : 1273 - 1283
  • [2] Adjuvant Therapy for HER2-Positive Breast Cancer
    Slomski, Anita
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (12): : 1134 - 1134
  • [3] Adjuvant treatment for HER2-positive breast cancer
    Burki, Talha Khan
    [J]. LANCET ONCOLOGY, 2015, 16 (02): : E59 - E59
  • [4] Adjuvant trastuzumab for HER2-positive breast cancer
    Spicer, J
    Harries, M
    Ellis, P
    [J]. LANCET, 2005, 366 (9486): : 634 - 634
  • [5] The Adjuvant Treatment of HER2-Positive Breast Cancer
    Danijela Jelovac
    Antonio C. Wolff
    [J]. Current Treatment Options in Oncology, 2012, 13 : 230 - 239
  • [6] The Adjuvant Treatment of HER2-Positive Breast Cancer
    Jelovac, Danijela
    Wolff, Antonio C.
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (02) : 230 - 239
  • [7] Concurrent administration of trastuzumab and anthracyclines as adjuvant regimen for HER2-positive breast cancer: a randomised controlled trial
    Shen, Songjie
    Xu, Ying
    Zhou, Yidong
    Mao, Feng
    Guan, Jinghong
    Sun, Qiang
    [J]. ONCOTARGET, 2017, 8 (54) : 92778 - 92787
  • [8] Adjuvant Trastuzumab in HER2-Positive Breast Cancer REPLY
    Slamon, Dennis J.
    Buyse, Marc
    Press, Michael F.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (07): : 663 - 665
  • [9] Adjuvant trastuzurnab therapy for HER2-Positive breast cancer
    Jahanzeb, Mohammad
    [J]. CLINICAL BREAST CANCER, 2008, 8 (04) : 324 - 333
  • [10] Is there a role for adjuvant pertuzumab in HER2-positive breast cancer?
    Mazzotta, Marco
    Barba, Maddalena
    Pizzuti, Laura
    Vici, Patrizia
    [J]. TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S281 - S284
12345